|
Differential effects of linear and cyclic polyamines on NMDA receptor activities., Masuko T., Neurochem Int. July 1, 2008; 53 (1-2): 38-44.
|
|
Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor., Chang HR., J Med Chem. March 27, 2008; 51 (6): 1534-45.
|
|
Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors., Masuko T., Neuropharmacology. September 1, 2007; 53 (4): 515-23.
|
|
Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor., Masuko T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
|
|
Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors., Kashiwagi K., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
|
|
Staggering of subunits in NMDAR channels., Sobolevsky AI., Biophys J. December 1, 2002; 83 (6): 3304-14.
|
|
Mutation of structural determinants lining the N-methyl-D-aspartate receptor channel differentially affects phencyclidine block and spermine potentiation and block., Zheng X., Neuroscience. January 1, 1999; 93 (1): 125-34.
|
